JF
PRME icon

Jump Financial’s Prime Medicine PRME Stock Holding History

Jump Financial’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.58M Buy
+1,240,429
New +$4.12M 0.04% 557
2026
Q1 		– Sell
-171,931
Closed -$597K – 2303
2025
Q4 		$597K Buy
+171,931
New +$765K 0.01% 1229
2023
Q2 		– Sell
-32,500
Closed -$400K – 2089
2023
Q1 		$400K Buy
+32,500
New +$529K 0.02% 993

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Jump Financial's PRME Position: Q2 2026 in Review

Jump Financial opened a new position in Prime Medicine (PRME) in Q2 2026: 1,240,429 shares worth $4.58M. The stake represents 0.04% of the portfolio and ranks #557 among its holdings. This is a return to the name: Jump Financial previously reported a position in PRME as recently as Q4 2025.

Jump Financial first reported a position in PRME in Q1 2023 and has held it in 3 quarters since. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Jump Financial held 1,240,429 shares of Prime Medicine worth $4.58M as of Q2 2026.
  • Prime Medicine was a new Jump Financial position in Q2 2026.
  • Prime Medicine made up 0.04% of Jump Financial's portfolio in Q2 2026, its #557 holding.
  • Jump Financial first reported a position in Prime Medicine in Q1 2023 and has held it in 3 quarters since.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.